Xenon Pharmaceuticals Inc.
XENE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582313
In the last 90 days, Xenon Pharmaceuticals Inc. insiders filed 2 open-market purchases and 2 sales; 315 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; Duquesne Family Office is the only superinvestor holding it.
Q4 2022 vs. Q3 2022
How the institutions holding Xenon Pharmaceuticals Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 154 | 159 | +5 |
| Shares | 57.9M | 60.4M | +2.51M (+4.3%) |
| Value | $2.09B | $2.38B | +$291.8M (+14.0%) |
New holders (22)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (17)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Acuta Capital Partners, LLC | 272,500 | $9.84M |
| Two Sigma Investments, LP | 55,974 | $2.02M |
| UBS Oconnor LLC | 54,208 | $1.96M |
| Bridger Management, LLC | 45,235 | $1.63M |
| Fred Alger Management, LLC | 45,143 | $1.63M |
| Difesa Capital Management, LP | 24,500 | $884.0K |
| HRT Financial LP | 15,927 | $574.0K |
| Victory Capital Management Inc | 12,228 | $441.0K |
| Oppenheimer & Co Inc | 11,113 | $401.0K |
| Squarepoint Ops LLC | 10,605 | $383.0K |
| Dynamic Technology Lab Private Ltd | 9,990 | $361.0K |
| Occudo Quantitative Strategies LP | 7,263 | $262.0K |
| Walleye Trading LLC | 5,603 | $202.0K |
| Amundi | 3,581 | $133.0K |
| Quantbot Technologies LP | 1,300 | $46.0K |
| Macquarie Group Ltd | 132 | $24.0K |
| Simplex Trading, LLC | 432 | $15.0K |